Disposable Ureteroscope Market Size, Share & Trends Analysis Report By Product (Flexible Ureteroscope, And Rigid Ureteroscope), By Application, By End-use And Segment Forecasts, 2022 - 2030

Report Overview

The global disposable ureteroscope market size was valued at USD 241.6 million in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 17.8% over the forecast period. The market is experiencing growth due to a rising number of ailments, such as urethral stricture, kidney stones (urolithiasis), and kidney cancer due to lifestyle changes like less consumption of water, and higher intake of alcoholic beverages and aerated drinks, dietary changes, and lack of physical activities. Disposable ureteroscopes reduce the rate of hospital-acquired infections and decrease contamination risk, thus, providing higher-quality patient care with improved economic viability. The introduction of stringent regulations to lower the risk of ureteroscopy-related infections has increased the demand for ureteroscopes for treating urolithiasis, urothelial carcinoma, and benign prostatic hyperplasia.

The rising trend of minimally invasive procedures also called one-day surgeries has led to a rise in the adoption of disposable ureteroscope by endoscopists and surgeons for diagnosing and treating renal diseases and multiple urological conditions. The benefits associated with these procedures are lesser collateral tissue damage, a quicker recovery which results in shortened hospitalization time, and reduced postoperative complications and care. Furthermore, compared to open surgeries, these minimally invasive procedures are more economically viable. Other factors such as improvement in the visualization of endoscopic devices and the introduction of robot-assisted endoscopy are further opening new opportunities for revenue growth. Major players are concentrating on creating technologically advanced products in order to cater to the rising demand.

The rising penetration of chronic kidney diseases and rapid innovations in product performance and optical imaging are propelling the growth of the market. As per the data of CDC in 2021, the penetration rate of chronic kidney diseases was the highest among the population aged 65 years and above (38%), followed by the age group of 45-64 years (12%), and lastly, the 18-44 years old (6%). Population suffering from diabetes and cardiovascular diseases are highly susceptible to developing chronic kidney diseases, which would directly have a positive impact the growth as it will increase the demand for minimally invasive procedures such as ureteroscopy, which will lead to a steep rise in the procedural rate and thus, boosting the adoption of ureteroscopy. The sudden shift to disposable ureteroscopes from reusable ureteroscopes in diagnosing and treating urologic conditions as it lowers post-operative complication and infection rates are driving the market growth.

Increasing prevalence of obesity further drives revenue growth as it has been observed that obese people have higher chances of developing kidney stones. In addition, for the diagnosis and treatment of the obese population, a ureteroscope is highly considered, as they suffer greater anesthetic risk and other treatments like percutaneous nephrolithotomy or shock wave lithotripsy are often unsuccessful. In addition, the high cost of technologically advanced products and lack of skilled labor is expected to hamper the growth in the forecast period of 2022-2030.

COVID-19 impacted the pace of market growth as all the outpatient treatments were postponed to lower the risk of viral transmission. The pandemic led to the implementation of travel restrictions and lockdowns which resulted in the transformation of healthcare facility’s setup. The healthcare sector prioritized procedures on the basis of emergent and non-emergent, which led to postponement and reduction in the number of surgeries and damaged the market growth. Furthermore, disruption of the supply chain and regulatory concerns further restraint the growth.

Product Insights

On the basis of product, flexible ureteroscope holds the largest market share of 89.5% and is also expected to grow with the fastest CAGR over the forecast period. The past few years have witnessed huge improvements in terms of technology and clinical applications. Disposable flexible ureteroscope has undergone a series of advancement and thus, are widely used for diagnosis and therapeutic applications for multiple upper urinary tract pathologies. The flexible ureteroscope allows complete mobility of 180 degrees and also reduces the time frame of hospital stays.

Furthermore, the introduction of single-use digital flexible ureteroscope has opened new opportunities for the market as it provides detailed HD images for removing stones more efficiently and safely. Rigid ureteroscope is also expected to witness lucrative growth over the forecast period. Technological upgradation of rigid ureteroscope has reduced the sheath size of the caliber while providing a wide working channel. Although, a flexible ureteroscope permits high maneuverability but still provides a smaller working channel.

Application Insights

On the basis of application, urolithiasis holds the largest market share of 49.0% in the year 2021. The growth is majorly attributed to the worldwide prevalence of kidney stones. For instance, as per the article of Kidney International Org., kidney stones are a very common health disorder on the Western side of the world with a reported prevalence of 10-12% in men and 5-6% in women for a lifetime. Growing innovations and rapid adoption of advanced technology is expected to drive the market growth of this segment. Growing awareness of the disease among the patient population, presence of a large number of specialty clinics, and favorable government policies further drives the market growth.

However, others segment is expected to show the fastest CAGR growth of 21.4% over the forecast period. The growth can be attributed to rising cases of cancers such as urothelial carcinoma and urethral cancer. As per the article by the American Cancer Society, kidney cancer is among the most common type of cancer, and the penetration of kidney cancer among men is about 1 in 46 males, whereas, in women, it is about 1 in 80 females.

End-Use Insights

Based on the end-use the market is segmented into hospitals, clinics and diagnostic centers. Among them, hospitals hold the largest share of 47.5% as patients majorly prefer hospitals for ureteroscopy procedures due to the presence of skilled healthcare professionals and favorable reimbursement policies. Expansion of healthcare infrastructure, adoption of advanced technology, and worldwide increasing investment in the hospital sector further drive the market growth.

Growing cases of urolithiasis is positively impacting the market growth. For instance, as per the report of NCBI, about 9% of the U.S. population suffers from urinary stones every year. Increasing healthcare spending, rising trend of minimally invasive procedures, and advancement in the designing of products also contribute to the market growth of the segment.

However, clinics are expected to show the fastest CAGR growth of 19.2% over the forecast period of 2022-2030. The growth of the segment is attributed to a growing number of specialty clinics throughout the world and increasing healthcare spending in the private sector.

Regional Insights

North America dominated the market in 2021 and accounted for the largest revenue share of 41.7%. The growth of the market can be attributed to the presence of a highly-established healthcare system and the presence of key players within the region like Elmed Medical Systems, Boston Scientific, and Stryker. Other factors such as favorable reimbursement policies, patient awareness, and the adoption of advanced instruments are also supporting the market growth. Growing cases of pediatric stones in the region is also driving the market. As per the report of NIH, there has been a steep rise in the cases of kidney stones among young as well as adults in the U.S. due to increased salt intake, lowered fluid consumption, and obesity. Thus, further driving the market growth.

On the other hand, Asia Pacific is anticipated to register the fastest growth rate of 19.7% over the forthcoming years owing to the growing population, favorable government initiatives & support. Rising cases of kidney stones due to changes in climatic conditions and dietary habits boost the market expansion. For instance, according to NCBI, 1 in every 17 adults is affected by kidney stones in China. In addition, growing investment in the R&D sector, expansion of healthcare infrastructure, and the growing obese population is driving the market growth in the coming future.

Key Companies & Market Share Insights

The key participants in the disposable ureteroscope market are introducing various strategic initiatives to expand their business footprint and gain a competitive edge in the market. Key players are focusing on strategic initiatives such as collaborations, funding & investments, mergers & acquisitions, partnerships, and the launching of an innovative product to expand their product portfolio. For instance, in April 2019, Dornier MedTech introduced AXIS disposable digital flexible ureteroscope in the U.S. Some of the prominent players in the global disposable ureteroscope market are:

• Boston Scientific Corporation

• Richard Wolf GmbH

• Olympus Corporation

• FUJIFILM Holdings Corporation

• Karl Storz GmbH

• Smith & Nephew Inc.

• PENTAX Medical

• Elmed Electronics & Medical Systems S.A.

• Dornier MedTech

• OPCOM

• AED.MD 

Disposable Ureteroscope Market Report Scope

Global Disposable Ureteroscope Market Segmentation

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of industry trends in each of the sub-segments from 2016 to 2030. For this study, Grand View Research, Inc. has segmented the global disposable ureteroscope market report based on product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2016 - 2030)

  • Flexible Ureteroscopes

  • Rigid Ureteroscopes

• Application Outlook (Revenue, USD Million, 2016 - 2030)

  • Urolithiasis

  • Urethral Stricture

  • Kidney Cancer

  • Others

• End-Use Outlook (Revenue, USD Million, 2016 - 2030)

  • Hospitals

  • Clinics

  • Diagnostic Centers

• Regional Outlook (Revenue, USD Million, 2016 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

    • Russia

    • Denmark

    • Switzerland

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • New Zealand

    • Indonesia

    • Malaysia

    • Vietnam

    • Philippines

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • UAE

    • Saudi Arabia

    • Qatar

    • Israel

    • Kuwait